ISAL 2019 | Critical care management of CAR-T related toxicities

Name: Critical care management of CAR-T related toxicities
Uploaded: 2019-02-24T00:00:00.000Z
Duration: 1 min 20 s
Description: New CAR T-cell treatments can ellicit immune-related adverse events, including cytokine release syndrome and neurotoxicity, which require critical care management. We spoke to Élie Azoulay, MD, PhD, of Hôpital Saint-Louis, Paris, France, at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, about this important emerging area.

Élie Azoulay • 24 Feb 2019

ISAL 2019

General CAR-T

New CAR T-cell treatments can ellicit immune-related adverse events, including cytokine release syndrome and neurotoxicity, which require critical care management. We spoke to Élie Azoulay, MD, PhD, of Hôpital Saint-Louis, Paris, France, at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, about this important emerging area.